Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development

Mesenchymal stromal cells (MSCs) have been considered a therapeutic strategy in regenerative medicine because of their regenerative and immunomodulatory properties. The translation of MSC-based products has some challenges, such as regulatory and scientific issues. Quality control should be standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebelatto, Carmen Lúcia Kuniyoshi, Boldrini-Leite, Lidiane Maria, Daga, Debora Regina, Marsaro, Daniela Boscaro, Vaz, Isadora May, Jamur, Valderez Ravaglio, de Aguiar, Alessandra Melo, Vieira, Thalita Bastida, Furman, Bianca Polak, Aguiar, Cecília Oliveira, Brofman, Paulo Roberto Slud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455270/
https://www.ncbi.nlm.nih.gov/pubmed/37629136
http://dx.doi.org/10.3390/ijms241612955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455270/
https://www.ncbi.nlm.nih.gov/pubmed/37629136
http://dx.doi.org/10.3390/ijms241612955

Ejemplares similares